Pharmacin

Pharmacin Takes Developing World-Class New Drugs as Its Responsibility and Improving Clinical Efficacy of Drugs as Its Mission. Established in 2016, Pharmacin’s core team is composed of scientists and expert consultants from well-known American pharmaceutical companies, possessing extensive capabilities in global commercial value judgment and channel resource integration. The company is committed to the R&D and industrialization of differentiated "innovative drugs + improved innovative drugs" with controllable risks and promising prospects. Adhering to the concept of “patient needs as the foundation, technological innovation as the priority,” Pharmacin leverages its technical advantages in the development of oral formulations for poorly soluble drugs. Utilizing the “China-US Cross-Border Innovative Drug Development Platform” that integrates scientific research transformation, intellectual property, and registration regulations, the company incubates world-class new drugs, facilitates the transformation between technological concepts and scientific research achievements, enhances patient welfare, and builds a healthier future.